Solid Biosciences, Inc.

Solid Biosciences, Inc.

Solid Biosciences, Inc.

Overview
Date Founded

2013

Headquarters

141 Portland Street,5th floor,Cambridge, MA 02139

Type of Company

Public

Employees (Worldwide)

111

Industries

Biotechnology
Medical Support Services
Pharmaceuticals

Company Description

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Solid Biosciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder, President & Chief Executive Officer

Co-Founder & Board Member

Chairman

Chief Accounting Officer, Chief Financial Officer & Treasurer

Chief Operating Officer

Chief Technology Officer

Chief Scientific Officer

Chief Legal Officer & Secretary

Chief Medical Officer

Head-Patient Advocacy

Board of Directors

Co-Founder at GreenLight Biosciences, Inc.

Former Vice President & Head-Medical Affairs at Quest Diagnostics, Inc.

Managing Director at Bain Capital Life Sciences LP

Co-Head of the Global Healthcare Investment Banking Group at JPMorgan Chase & Co.

Managing Partner at RA Capital Management LLC

Founder & CMO at Civitas Therapeutics, Inc.

Chief Investment Officer at Perceptive Advisors LLC

Chief Financial Officer at Compass Therapeutics LLC

Co-Founder, President & Chief Executive Officer at Solid Biosciences, Inc.

Co-Founder & Board Member at Solid Biosciences, Inc.

Paths to Solid Biosciences, Inc.
Potential Connections via
Relationship Science
You
Solid Biosciences, Inc.
Owners & Shareholders
Details Hidden

Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. Perceptive Advisors advises two separate master-feeder private fund structures.The Perceptive Life Sciences Funds invest in the equities of growth healthcare companies and value plays, with an emphasis on biotechnology. Perceptive Advisors seeks to identify opportunities to exploit relative value disparities and inefficiencies that exist on both the long and short side of the market. They focus on a universe of about 300 smaller, more inefficiently priced companies which are underfollowed by Wall Street biotechnology analysts. Hedging strategies using long and short equity positions, equity options, and index options are used in an attempt to reduce and control risk.The Perceptive Credit Opportunity Fund seeks to achieve superior risk-adjusted returns by investing in senior secured loans and other debt and debt-related instruments issued by small- and mid-cap publicly traded companies and privately-held emerging growth companies primarily in the healthcare and related industries. The fund's investments may be originated by the fund or in collaboration with a syndicate of other credit investors. Most of the fund's investments will be structured as directly originated loans to healthcare companies.Perceptive Advisors also advises two separate accounts. The investment strategies of the separate accounts are substantially similar to those of the Perceptive Life Sciences Fund, though the separate accounts may take more concentrated positions and use a higher degree of leverage.

Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Details Hidden

Tavistock Life Sciences invests in a portfolio of public companies and private equity crossover opportunities. Investments tend to focus on focus on biotechnology drug development companies across multiple therapeutic indications.

Recent Transactions
Details Hidden

Solid Biosciences, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onSolid Biosciences, Inc. issued USD Common Stock

Escrow Agent

Advised onSolid Biosciences, Inc. issued USD Common Stock

Underwriter

Advised onSolid Biosciences, Inc. issued USD Common Stock

Legal Advisor

Advised onSolid Biosciences, Inc. issued USD Common Stock

Legal Advisor

Advised onSolid Biosciences, Inc. issued USD Common Stock

Associate

Advised onSolid Biosciences, Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Member, Board of Scientific & Clinical Advisors at Audentes Therapeutics, Inc.

Advisor

Associate Professor at University of Missouri System

Advisor

Member, Scientific Advisory Board at Solid Biosciences, Inc.

Key Stats and Financials As of 2018
Market Capitalization
$184M
Total Enterprise Value
$770M
Earnings Per Share
$-2.25
Revenue
$0
Net Profit
$-74.8M
EBITDA
$-74.1M
Total Debt
$1.03M
Total Equity
$125M
TEVNet Income
-10.29x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Investors
Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Details Hidden

Bain Capital Life Sciences primarily focuses on controlling equity investments, inflection capital, growth capital and fallen angels. The firm invests biopharmaceutical, medical device, diagnostics and enabling life science technology companies. The firm may also recommend other types of investments consistent with the respective of their fund's investment strategy and objectives.

Details Hidden

Cormorant invests in companies primarily located in North America. The firm targets companies in sectors such as life-science and biotech. It provides equity financing for later stage capital requirements.

Suppliers
Harvard University Schools & Student Services | CAMBRIDGE, MA

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

University of Missouri - Columbia Management Consulting | COLUMBIA, MISSOURI

University of Missouri was founded in 1839 in Columbia, Missouri. MU is a major land-grant institution and Missouri's largest public research university. It is one of only 34 public universities, and the only public institution in Missouri, to be selected for membership in the Association of American Universities. MU offers more than 280 degree programs including more than 75 online degree options and is designated as comprehensive doctoral with medical/veterinary by the Carnegie Foundation for the Advancement of Teaching.

University of Michigan Other Business & Consulting Services | Ann Arbor, MI

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

Competitors
Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Sarepta Therapeutics, Inc. Pharmaceuticals - Cambridge, Massachusetts

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

PTC Therapeutics, Inc. Pharmaceuticals - South Plainfield, NJ

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Solid Biosciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Solid Biosciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Solid Biosciences, Inc..